These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33863543)

  • 1. Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis.
    Fuentes AM; Chiu RG; Mehta AI
    J Clin Neurosci; 2021 May; 87():92-96. PubMed ID: 33863543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and clinical features of moyamoya disease in the USA.
    Kainth D; Chaudhry SA; Kainth H; Suri FK; Qureshi AI
    Neuroepidemiology; 2013; 40(4):282-7. PubMed ID: 23445954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
    Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
    Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid Autoantibodies and the Clinical Presentation of Moyamoya Disease: A Prospective Study.
    Lanterna LA; Galliani S; Zangari R; Conti L; Brembilla C; Gritti P; Colleoni ML; Bernucci C
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1194-1199. PubMed ID: 29305275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nationwide survey on quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Moyamoya Syndrome in Appalachia.
    Nisiewicz MJ; Roberts JM; Dobbs MR; Ajadi EA; Kitzman P; Wolfe M; Elkins K; Dugan AJ; Fraser JF
    Cerebrovasc Dis; 2020; 49(5):516-521. PubMed ID: 33027801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moyamoya vasculopathy - Patient demographics and characteristics in the Finnish population.
    Saarela M; Mustanoja S; Pekkola J; Tyni T; Hernesniemi J; Kivipelto L; Tatlisumak T
    Int J Stroke; 2017 Jan; 12(1):90-95. PubMed ID: 27625049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult moyamoya disease in an urban center in the United States is associated with a high burden of watershed ischemia.
    Zafar SF; Bershad EM; Gildersleeve KL; Newmark ME; Calvillo E; Suarez JI; Venkatasubba Rao CP
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological features of moyamoya disease in Japan.
    Hoshino H; Izawa Y; Suzuki N;
    Neurol Med Chir (Tokyo); 2012; 52(5):295-8. PubMed ID: 22688065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Natural History of Quasi-Moyamoya Disease.
    Zhao M; Lin Z; Deng X; Zhang Q; Zhang D; Zhang Y; Wang R; Wang S; Jiang Z; Wang H; Zhao J
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1088-1097. PubMed ID: 28109734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disease presentation of Moyamoya angiopathy in Eastern India.
    Das S; Dubey S; Acharya M; Ghosh R; Chatterjee S; Hazra A; Lahiri D; Segupta S; Chatterjee S; Das G; Sarkar N; Ray BK; Kraemer M
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104957. PubMed ID: 32689603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of concurrent down syndrome in patients with moyamoya disease.
    Kainth DS; Chaudhry SA; Kainth HS; Suri FK; Qureshi AI
    Neurosurgery; 2013 Feb; 72(2):210-5; discussion 215. PubMed ID: 23149966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moyamoya in a non-Asian patient: a case report and review of the literature.
    Felbaum D; Henning E; Payne BR
    W V Med J; 2012; 108(2):16, 18-9. PubMed ID: 22655430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya disorder in the United States.
    Starke RM; Crowley RW; Maltenfort M; Jabbour PM; Gonzalez LF; Tjoumakaris SI; Randazzo CG; Rosenwasser RH; Dumont AS
    Neurosurgery; 2012 Jul; 71(1):93-9. PubMed ID: 22418580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of moyamoya disease in Taiwan: a nationwide population-based study.
    Chen PC; Yang SH; Chien KL; Tsai IJ; Kuo MF
    Stroke; 2014 May; 45(5):1258-63. PubMed ID: 24676775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Prevalence of Cerebrovascular Disease in Hospitalized Patients with Marfan Syndrome.
    Kim ST; Cloft H; Flemming KD; Kallmes DF; Lanzino G; Brinjikji W
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):296-300. PubMed ID: 29030048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural clinical course of hemodynamically stable adult moyamoya disease.
    Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
    J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of asymptomatic microbleeds in patients with moyamoya disease.
    Ishikawa T; Kuroda S; Nakayama N; Terae S; Kudou K; Iwasaki Y
    Neurol Med Chir (Tokyo); 2005 Oct; 45(10):495-500; discussion 500. PubMed ID: 16247234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Hemorrhage-prone Anastomoses in Asymptomatic Moyamoya Disease-A Comparative Study with Japan Adult Moyamoya Trial.
    Yamamoto S; Funaki T; Fujimura M; Takahashi JC; Uchino H; Houkin K; Tominaga T; Miyamoto S; Kuroda S;
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104328. PubMed ID: 31471213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.